1-15765096-G-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_017556.4(FBLIM1):c.113G>A(p.Arg38Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00249 in 1,613,872 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_017556.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBLIM1 | NM_017556.4 | c.113G>A | p.Arg38Gln | missense_variant | 3/9 | ENST00000375766.8 | NP_060026.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBLIM1 | ENST00000375766.8 | c.113G>A | p.Arg38Gln | missense_variant | 3/9 | 2 | NM_017556.4 | ENSP00000364921.3 |
Frequencies
GnomAD3 genomes AF: 0.00235 AC: 358AN: 152200Hom.: 2 Cov.: 31
GnomAD3 exomes AF: 0.00390 AC: 972AN: 249050Hom.: 6 AF XY: 0.00462 AC XY: 623AN XY: 134834
GnomAD4 exome AF: 0.00250 AC: 3660AN: 1461554Hom.: 22 Cov.: 31 AF XY: 0.00294 AC XY: 2139AN XY: 727102
GnomAD4 genome AF: 0.00236 AC: 359AN: 152318Hom.: 2 Cov.: 31 AF XY: 0.00251 AC XY: 187AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 08, 2022 | Variant summary: FBLIM1 c.113G>A (p.Arg38Gln) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0039 in 249050 control chromosomes in the gnomAD database, including 6 homozygotes. In addition, a study by Kars et al (2021) investigated the genetic structure of Turkey from 3,362 unrelated subjects and detected the variant in 18 homozygous individuals. c.113G>A has been reported in the literature in individuals affected with Chronic Osteomyelitis and developmental delay or intellectual disability (Cox_2017, dAdamo_2020, Hiraide_2021). These reports do not provide unequivocal conclusions about association of the variant with FBLIM1-Related Disorders. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | FBLIM1: BP4, BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at